Skip to contentK
Kyntra Bio, Inc.
K
KYNBKyntra Bio, Inc. Q1 2019 · 10-Q
Revenue$23.86M$23.86M−25.3% vs Q1 2018 Net Income-$45.41M-$45.41MN/M vs Q1 2018 EPS Diluted-$0.53-$0.53N/M vs Q1 2018 Operating Income-$48,843,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kyntra Bio, Inc. · CIK 921299 · Engraved from SEC EDGAR
Free Cash Flowderived$21,997,000N/M Margins · derivedOperating margin-204.7%−77.5 pt vs Q1 2018
Net margin-190.3%−60.6 pt vs Q1 2018
ended Mar 31, 2019 · filed May 9, 2019 · 39 d after period end